🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 7 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/01/2000 23,13 27,25 22,38 22,94 -8,71% 21,08% 458.400
03/01/2000 26,00 28,50 21,88 25,13 +1,52% 25,48% 292.200
31/12/1999 24,56 25,50 24,06 24,75 +0,51% 5,85% 40.600
30/12/1999 28,75 29,13 24,50 24,63 -12,83% 16,09% 397.200
29/12/1999 26,38 29,63 25,25 28,25 +8,13% 16,59% 372.400
28/12/1999 22,13 26,50 21,13 26,13 +19,09% 24,29% 403.200
27/12/1999 22,75 23,44 20,38 21,94 -3,57% 13,46% 89.400
23/12/1999 20,63 23,50 20,63 22,75 +10,30% 13,94% 687.900
22/12/1999 20,50 20,75 19,81 20,63 +0,30% 4,57% 359.700
21/12/1999 21,88 22,00 19,75 20,56 -6,53% 10,29% 283.500
20/12/1999 21,75 23,00 20,50 22,00 +1,73% 11,49% 394.700
17/12/1999 19,00 22,00 19,00 21,63 +14,57% 15,79% 769.600
16/12/1999 18,38 18,88 17,75 18,88 +2,03% 6,12% 395.400
15/12/1999 18,50 18,56 18,19 18,50 -2,63% 2,03% 441.700
14/12/1999 19,13 19,88 18,75 19,00 -4,10% 5,88% 869.900
13/12/1999 16,38 20,00 16,38 19,81 +26,80% 22,14% 1.348.100
10/12/1999 13,31 15,63 12,75 15,63 +15,74% 21,60% 3.017.500
09/12/1999 15,06 15,31 13,25 13,50 -10,74% 13,69% 292.100
08/12/1999 15,56 15,63 14,50 15,13 -3,20% 7,23% 473.000
07/12/1999 16,38 16,38 15,25 15,63 -5,30% 6,87% 315.000
06/12/1999 16,38 17,00 15,69 16,50 -1,49% 8,02% 396.900
03/12/1999 17,25 18,38 16,69 16,75 -4,29% 9,78% 1.185.900
02/12/1999 15,00 17,75 14,38 17,50 +16,67% 22,50% 1.685.200
01/12/1999 12,25 15,13 12,25 15,00 +13,21% 23,47% 824.100
30/11/1999 14,63 14,63 11,25 13,25 -8,23% 23,08% 742.700
29/11/1999 15,94 16,00 13,50 14,44 -3,75% 15,69% 908.700
26/11/1999 13,50 15,13 13,44 15,00 +11,63% 12,50% 291.400
24/11/1999 14,00 14,13 13,13 13,44 -4,02% 7,14% 438.200
23/11/1999 15,00 16,00 13,00 14,00 -5,49% 20,00% 799.600
22/11/1999 11,63 14,81 11,31 14,81 +32,40% 30,11% 1.434.100